Sort
21,453 grants matching “tuberculosis”
PHRU-Setshaba Clinical Trials Unit
$2,607,238Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2024 · AI
CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment
$2,604,795Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2019 · AI
UZ-UCSF CTU
$2,602,648Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2016 · AI
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,602,536Magdalena Elzbieta Sobieszczyk · Columbia University Health Sciences · UM1 · FY2025 · AI
Host Pathogen Variation & TB Pathogenesis
$2,599,143Thomas R Hawn · University Of Washington · U19 · FY2023 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$2,598,246Kathy Penrose · City Of Houston · U52 · FY2006 · PS
Tuberculosis Imaging Program
$2,596,620Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2022 · AI
Epidemiology and transmission dynamics of MDR/XDR tuberculosis
$2,596,567Megan B Murray · Brigham And Women'S Hospital · U19 · FY2007 · AI
Sequencing Core
$2,595,356James C Sacchettini · Harvard Medical School · U19 · FY2018 · AI
FEND-TB
$2,593,818Jerrold J. Ellner · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Bronchiectasis and chronic airway infection
$2,591,429Kenneth Olivier · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Structural Genomics of Persistence Targets from M. tuberculosis
$2,591,314James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2008 · AI
Genes And Gene Products As Immunoadjuvants
$2,589,919Steven M Holland · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Host Pathogen Variation & TB Pathogenesis
$2,586,191Thomas R Hawn · University Of Washington · U19 · FY2022 · AI
Host Pathogen Variation & TB Pathogenesis
$2,583,647Thomas R Hawn · University Of Washington · U19 · FY2024 · AI
Determinants of TB control, relapse and reinfection
$2,583,322Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2022 · AI
Tuberculosis Elimination and Laboratory Cooperative Agreement
$2,583,222Rose Sales · Georgia State Departmentof Public Health · U52 · FY2015 · PS
Determinants of TB control, relapse and reinfection
$2,583,036Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2024 · AI
Case Clinical Trials Unit
$2,582,654Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2022 · AI
Decoding the roles of critical genes of unknown function in M. tuberculosis
$2,581,462Eric Joseph Rubin · Harvard School Of Public Health · U19 · FY2016 · AI
Decoding the roles of critical genes of unknown function in M. tuberculosis
$2,581,462Eric Joseph Rubin · Harvard School Of Public Health · U19 · FY2017 · AI
Decoding the roles of critical genes of unknown function in M. tuberculosis
$2,581,322Eric Joseph Rubin · Harvard School Of Public Health · U19 · FY2014 · AI
Metabolic determinants of Mtb virulence, vulnerability and variation
$2,578,114David Branch Moody · Brigham And Women'S Hospital · U19 · FY2022 · AI
Vanderbilt HIV Clinical Trials Unit (CTU)
$2,577,612David W Haas · Vanderbilt University Medical Center · UM1 · FY2021 · AI
Bronchiectasis and chronic airway infection
$2,577,172Kenneth Olivier · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL